Bigul

Novartis India Ltd - 500672 - Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited ('The Company') Held On February 11, 2020

Kindly note that the Board of Directors of the Company has in its meeting held today i.e. on Tuesday, February 11, 2020 ("said meeting"), inter alia considered and approved the Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31, 2019. The said Meeting commenced at 11:00 a.m. and concluded at 5:00 p.m. Further, in terms of the applicable provisions of SEBI Listing Regulations, please find enclosed herewith: a. the Unaudited Financial Results; b. Limited Review Report dated February 11, 2020, issued by the Statutory Auditors of the Company with respect to the Unaudited Financial Results and taken on record by the Board of Directors of the Company. The above is for your information and the same is also available on the Company''s website i.e. www.novartis.in Thanking you
11-02-2020

Indian pharma sector's growth slips to 7.6% in January, anti-diabetes segment a drag

The patents for Vildagliptin in India, held by Novartis, expired on December 9, opening the market for cheap rip-offs.
10-02-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sirs, Please note that in terms of the applicable provisions of the SEBI Listing Regulations, the Company has received intimation regarding loss of share certificate from the following shareholder: Stop transfer date - January 22, 2020 Folio No. 02331942 Name - Suman Bahal Certificate No. - 24203 Distinctive No. - 16140479 - 16140558 No. of Shares - 80 Reason - Lost by holder The Registrar and Share Transfer Agent of the Company i.e. Link lntime India Private Limited has received a request letter from the abovementioned shareholder and have informed the Company about the same today i.e. on January 24, 2020. Further, subject to completion of required formalities by the shareholder, the Company will issue duplicate share certificate in lieu thereof. Thanking you
24-01-2020
Bigul

NOVARTIS INDIA LTD. - 500672 - Shareholding for the Period Ended December 31, 2019

Novartis India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
21-01-2020
Bigul

Novartis India Ltd - 500672 - Statement Of Investor Complaints For The Quarter Ended December 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0440 Name of the Signatory :- Trivikram Guda Designation :- Company Secretary and Compliance Officer
15-01-2020
Bigul

Novartis India Ltd - 500672 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dear Sir/ Madam, In reference to the above captioned subject, the certificate dated January 15, 2020 issued by the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited, in terms of the provisions of the said Regulations, for the quarter ended on December 31, 2019 is enclosed herewith for your records as Annexure 1. This is for your information and record. Thanking you.
15-01-2020
Bigul

Novartis India Ltd - 500672 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Dear Sirs, Apropos the subject matter quoted above, please find enclosed herewith the copies of the newspaper Notices in 'Financial Express' and 'Navshakti' on December 24, 2019. This is for your information and record. Thanking You.
24-12-2019
Bigul

Novartis India Ltd - 500672 - Closure of Trading Window

Dear Sir/ Madam, Please be informed that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, February 11, 2020, to inter alia consider the Unaudited Financial results of the Company for the third quarter and nine-months ending on December 31, 2019 ("said results"). In this connection, further note that pursuant to the Company''s Code of Conduct to regulate, monitor and report share trading by Insiders ["the Code"], the trading window for dealing in securities of the Company shall remain closed from Wednesday, January 1, 2020 to Thursday, February 13, 2020 (both days inclusive). The same is being duly communicated to all the Designated Persons under the Code which is available on the Company''s website i.e. www.novartis.in. This is for your information.
23-12-2019
Bigul

Novartis India Ltd - 500672 - Board Meeting Intimation for The Date Of Board Meeting Which Is Scheduled On Tuesday, February 11, 2020.

NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2020 ,inter alia, to consider and approve the Unaudited Financial results of the Company for the third quarter and nine-months ending on December 31, 2019.
23-12-2019
Bigul

Novartis plans to give away 100 doses of world's costliest therapy to some patients

Novartis's AveXis unit, which developed Zolgensma will allocate 50 doses of the world's costliest single-dose treatment through June for babies under 2 years old, says Novartis
22-12-2019
Next Page
Close

Let's Open Free Demat Account